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ABSTRACT
Caulobacter is a well-studied bacterial genus, but little is known about the
plasmids that are found in some wild Caulobacter isolates. We identified nine plasmids
from seven different Caulobacter strains and grouped them based on their size and the
similarity of their repABC, parAB, and mobAB genes. Protein pathway analysis of the
genes on the K31p1, and K31p2 plasmids showed many metabolic pathways that would
enhance the metabolic versatility of the host strain. In contrast, the CB4 plasmid
contained 21 heavy metal resistance genes organized into 9 operons. The majority of
the CB4 heavy metal resistance genes code for genes that enhance copper resistance.
Growth assays demonstrated increased copper resistance and quantitative PCR showed
an increase in the expression of eight of the nine heavy metal operons when induced
with copper.
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CHAPTER 1
INTRODUCTION
Heavy metal poisoning is an ongoing threat to many ecosystems across the
planet due to increased pollution levels. As more toxic waste is released into the
environment, heavy metal levels will continue to rise. Plants are under a particular
threat since they have no ability to move to another habitat if theirs becomes polluted.
On the other hand, some plants can accumulate heavy metals, and they can be used to
remove heavy metals from a polluted environment (1). Bacteria within the Caulobacter
genus have been shown to have plant growth promoting activity, heavy metal
resistance, and the ability to colonize mineral rich soil (2,3). This combination of plant
growth promotion and heavy metal resistance could potentially benefit plants in
polluted environments. The heavy metal resistance and ability to colonize mineral rich
soil could benefit soil conservation projects as well.
Caulobacter crescentus is a well-studied (4) Alphaproteobacterium with a dimorphic life cycle (5). This unique life cycle combines a motile swarmer cell with a
nonmotile stalked cell, with DNA replication only occurring in the nonmotile stalked cell
(6). As a result, C. crescentus has been an excellent model system for the study of
cellular differentiation, asymmetric division, and cell cycle transition (7). To understand
the genetic underpinning of this unusual cell cycle, the genomes of Caulobacter strains
have been well studied over the years, yet not much has been reported on Caulobacter
1

plasmids (8,9). Plasmids are extra-chromosomal, independently replicating, linear or
circular DNA strands (10). They are present in many bacterial strains and been modified
through biotechnology techniques to be used for the addition, modification, or knockout of genes (11,12). The plasmids of Alphaproteobacteria have been found to fall into 3
groups based on size (14) with an average size of 4,623 bp, 68,377 bp, and 483,939 bp,
respectively. The larger plasmids within the Alphaproteobacteria are further classified as
repABC-type plasmids based on their replication genes (14). These plasmids also have
similar parAB genes, which are involved in the partitioning of the plasmids during cell
division (15).
Caulobacters reside in soil, freshwater, and saltwater environments (4), but have
been found to be more abundant in soil than in aquatic environments (16). Whitman et
al. (2), while looking at interactions between soil minerals and bacteria, found
Caulobacter henricii to be significantly enriched in their ferrihydrite mineral sample.
Ferrihydrite is the main iron oxide precursor in soil, and fixes heavy metal cations, such
as Сd2+, Cu2+, and Zn2+ (17). This interaction of ferrihydrite with heavy metals has been
utilized by soil scientists involved soil conservation.
As indicated above, recent studies have shown many Caulobacters to be plant
growth promoting bacteria (18,19). Plant growth promoting bacteria or PGPB have been
found to both promote growth and protect the plant from stress and disease. Luo et al.
(18) found that Caulobacter RHG1 increased leaf number and size, as well as lateral root
formation in Arabidopsis plants. Similarly, Yang et al. (3) detailed the potential
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biotechnological application of Caulobacter strain RHGG3 in relation to both its plant
growth promoting and heavy metal resistance.
To learn more about how Caulobacters interact with their environment, I
identified the plasmid sequences associated with Caulobacter genomes in GenBank, an
online database for sequences. The plasmids were then grouped and further analyzed to
look for important functionality that they could bring to the host Caulobacter strain. For
example, I found that the plasmid in the CB4 strain conferred heavy metal resistance to
the CB4 strain. The results of these analyses are presented in Chapter2.
Many of the Caulobacter strains have been shown to be difficult to electroporate
(20). This is mainly attributed to the S-layer, an array of ring structures each comprised
of six subunits of the RsaA protein and stabilized with Ca 2+ (21). For example, a mutant
S-layer deficient C. crescentus CB2 was shown to have 10 times the number of
electroporation transformants in relation to the wild type CB2 strain (20). Similarly, the
wild type C. henricii CB4 proved difficult to electroporate in an experiment with a
pBR322 plasmid containing two 250 bp sequences matching the CB4 plasmid copA gene.
To determine whether the problem lay with the CB4 strain or the plasmid, the
experiment was replicated with pXylTn5, a plasmid containing a transposon that is
known to randomly integrate into Caulobacter genomes in the presence of xylose (22).
Again, no transformants were obtained even though a control experiment with CB15, a
close relative of CB4 yielded approximately 100 transformants/plate. Therefore, we
hypothesized that the CB4 S-layer might be interfering with the electroporation process.
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Alternatively, the inability of CB4 to take up foreign DNA could also be attributed
to its EPS, or exopolysaccharide layer. In C. crescentus the EPS is a tetrasaccharide
capsule that is not easily removed through washing (23). We have observed that CB4
cells readily form clumps and electron microscopy images of CB4 have shown that an
EPS layer was present on the surface of CB4. Chapter 3 describes as series of
experiments performed in an attempt to find conditions that would generate a
successful electroporation event.
SARS-CoV 2 and blood clots
The coronavirus SARS-CoV2 has greatly affected the world since its immergence
in late 2019. The virus has seen various countries go in and out of lockdown in an
attempt to prevent its spread. The University of South Carolina had to end in-person
classes in the Spring of 2020 to lessen the spread. During this time, I read every journal
article I could find on SARS1, SARS2, and MERS. Originally, the severe cases of the virus
were attributed to pneumonia and sepsis, but surprisingly the first large autopsy studies
discovered blood clots in most organs and megakaryocyte cells in the lungs, kidneys,
and heart (24-26).
The cause of the megakaryocytes and blood clots was and is not fully
understood. Based upon the knowledge I had gained from all the SARS articles; I began
to devise a hypothesis as to why the blood clots were forming and find existing
treatment plans that target these mechanisms. Chapter 4 of my dissertation is a review
article hypothesizing the molecular mechanism leading to blood clots in sever COVID-19
patients.
4

CHAPTER 2
PLASMIDS BRING NOVEL FUNCTION TO CAULOBACTER GENOMES

Carter, T. To be submitted to Current Microbiolog
5

Introduction
Bacterial plasmids are extrachromosomal elements comprised of doublestranded DNA. Most well-studied bacterial plasmids confer antibiotic resistance, and
some are used for cloning and various gene expression studies. In contrast, naturally
occurring plasmids can house genes that are also found in chromosomal DNA as well as
genes that have never been found in a bacterial genome [10]. Plasmids often code for
proteins that can increase the growth of the host bacterium in the presence of a
selection factor, and in the absence of the selection factor, they usually reduce bacterial
fitness [2].
Numerous plasmids have been identified in the phylum Proteobacteria due to
the symbiotic relationships that these bacteria have with plants and animals [3]. In the
case of Alphaproteobacteria, the majority of known plasmids have been found in
Rhizobiales (143 plasmids), Rhodospirillales (122 plasmids), Rhodobacteriales (94
plasmids), and Sphingomonadales (65 plasmids) [4]. These plasmids have been sorted
into two groups based on the similarity of the predicted amino acid sequences of their
ParAB and RepABC proteins, which are required for the proper partitioning and
replication of the plasmid, respectively [5, 6]. Thus, all of the plasmids found to date in
Alphaproteobacteria appear to have diversified from two ancestral types of plasmids.
One of the best studied Alphaproteobacteria is Caulobacter crescentus a gramnegative bacterium with a dimorphic lifestyle. Each cell division results in the production
of both a stalked cell and a motile swarmer cell that has a single flagellum and multiple
pili [7]. After a period of growth, the swarmer cell loses the flagellum and pili and then
6

synthesizes a stalk to become a mature stalked cell. DNA replication and cell division
occur only in the stalked phase of the life cycle [8]. Since C. crescentus has a well-known
and easy to study cell cycle, it has been developed as a model organism for studying
cellular differentiation, asymmetric division, and cell cycle transition [9, 10]. For
example, the transcriptome analysis of the cell cycle [9], the genome nucleotide
sequence [11], and the essential genome [12] of Caulobacter crescentus have been
studied extensively.
While much is known about Caulobacter genomes [13, 14], not much is known
about Caulobacter plasmids [15]. Most of the sequenced Caulobacter genomes
uploaded to the online database GenBank do not contain plasmids. However, a few
Caulobacter plasmids have been identified including those present in the CB4, K31,
FWC26 and FWC2 wild type strains. The Local Adaptation Hypothesis [16] lays the
groundwork for why only some Caulobacter strains would have plasmids since
Caulobacters inhabit a wide variety of environments, and a plasmid could provide genes
needed for survival in a particular environment. However, when the bacteria do not live
in the presence of an environmental stressor such as a heavy metal, a plasmid
containing genes coding for proteins that confer heavy metal resistance would not have
the ability to increase host fitness, and therefore the bacteria could benefit from not
having to maintain the plasmid. This study analyzes the previously identified plasmids as
well as several previously unrecognized Caulobacter plasmids and shows that both types
of Alphaproteobacterial plasmids can be found among Caulobacter strains. In addition,
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we demonstrate that the C. henricii CB4 plasmid provides enhanced heavy metal
resistance to the host cells.
Methods
Bioinformatic analyses
The repC nucleotide sequence from K31p1 (accession NC_010335) and the repB
nucleotide sequence from the CB4 plasmid (accession CP013003) were submitted to
BLASTn in the GenBank database [17] to identify homologous sequences in other
Caulobacter genomes. The Caulobacter sequence matches above 40% predicted amino
acid identity for the repB or repC nucleotide sequence were further investigated for the
presence of the mob and par genes. Since plasmids should have circular genomes, the
nucleotide sequences of the presumed plasmids were downloaded from GenBank and
analyzed with UGENE [18] for sequence overlap within the ends of the contigs. In
contrast, a contig representing a portion of a chromosomal sequence would be part a
linear stretch of DNA and would not be expected to have overlapping ends. All plasmid
sequences examined except that of the ROOT1455 plasmid had overlapping sequences
at the ends of the contig. In contrast, the ROOT1455 contig appears to be missing some
of the plasmid sequence. The remaining plasmids were then trimmed to unit length and
uploaded to the RASTtk [19] annotation servers for gene annotation. The annotated
nucleotide sequences were then input into the Mauve software [20] for alignment with
the nucleotide sequences of the other plasmids in the same group. In addition, the
K31p1, K31p2, and CB4 plasmid sequences were analyzed using the PATRIC Protein
8

Family Sorter to predict the contributions of the plasmid encoded proteins to the
functional pathways of the host cells. Also, since several genes on the CB4 plasmid were
predicted to code for proteins that would contribute to heavy metal resistance, the
amino acid sequence of each gene on the CB4 plasmid was then used as input into
BLAST to identify additional heavy metal resistance genes. Genes were considered
homologous if they had at least 40% predicted amino acid identity with at least 60%
query coverage and an e-value <10-5. To determine whether some genes might be coexpressed from the same promoter, regions containing heavy metal resistance genes
were examined and contiguous genes separated by fewer than 40 bp were considered
to be expressed as an operon since it is unlikely that there would be sufficient space for
a separate promoter. This approach is deliberately conservative, and there may be
fewer operons than we proposed. Thus, our transcript analysis might include some
redundancy.
Copper resistance
To measure resistance to copper, a 200 ul aliquot of an overnight culture of CB4
or NA1000 was added to 5 mL of PYE [21] along with varying amounts of 10 mM CuSO 4.
After incubation for 24 hours at 30°C, growth yield was measured at 650 nm with a
Klett-Summerson colorimeter. For the mid-log phase growth assay, a 200 ul aliquot of
an overnight culture of CB4 or NA1000 was added to 10 mL of PYE and allowed to grow
at 30°C. When the cultures had grown to half of the expected level, 8 ul of 10 mM CuSO4
was added to each culture tube, and growth was monitored for 4 hours to determine
the impact of the CuSO4 on the growth rate.
9

Quantitative PCR
For the initial experiment, an overnight culture of CB4 was divided into four
tubes containing PYE and 16 uM CuSO4, 8 uM AgNO3, 100 uM ZnCl2, or no addition.
Precursor experiments showed that these metal concentrations did not inhibit CB4
growth. After 30 minutes at 30°C, total RNA was extracted from each tube using the
PROMEGA Bacterial RNA kit. DNaseI (Invitrogen) was used to eliminate any remaining
dsDNA, and PCR experiments confirmed that no dsDNA was present. Subsequently, a
ProtoScript II First Strand cDNA Synthesis Kit was used to create a cDNA library. The
resulting cDNA was used in a PCR reaction with each of the primer combinations
(Supplementary Table B.1), and an aliquot of the products was subjected to agarose
electrophoresis to estimate the amount of cDNA present from each gene of interest.
qPCR data was obtained from a BIOSYSTEMS 7300 utilizing the Luna Universal qPCR
Master Mix (New England Biolabs). Each sample and each gene were analyzed in
duplicate, with rho as the reference gene. The sample with no added metals was used as
a control. Subsequently, expression of operon 2 was measured by qPCR with CB4
cultures grown with three differing concentrations of copper, with 2 runs for each
sample. Similarly, expression of operons 4 and 5 were analyzed after growth with 16 um
copper for 30 minutes, with 3 runs for each sample, and the expression of operons 1, 3,
4, 5, 6, 7, 8, and 9 was determined after growth with 16 um copper for 30 minutes, with
2 runs for each sample. All genes determined to be induced by copper, displayed a
similar increase in expression across all experiments. However, the relative increase in
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expression for operon 4 was much more variable due to its extremely low expression in
the absence of copper.
Results
Caulobacter plasmids
As indicated above, Proteobacterial plasmids have previously been grouped
based on their partitioning (parAB) and replication (repABC) genes [4]. Consequently,
the repC nucleotide sequence from K31p1 and repB nucleotide sequence from CB4 were
used to identify homologous genes in Caulobacter genomes present in the GenBank
database. Some of the matching sequences were from sequences previously designated
as Caulobacter plasmids, and others matched individual contigs in partially sequenced
Caulobacter genomes that were present in the database. Unfortunately, most bacterial
genomes present in GenBank are a collection of contigs that represent a fragmented
genome since many laboratories have not switched to PacBio sequencing technologies
[22]. However, when plasmid repC or repB genes were found on a contig, our analyses
indicated that the contig represented the complete sequence of a plasmid that is
associated with that particular Caulobacter strain (except for the Root1455 plasmid as
noted in Methods). The plasmids identified by this analysis also contained the parAB
genes which would be required for the partitioning of the plasmid during replication.
The nine plasmids identified from seven Caulobacter strains ranged in length from
45,171 bp to 420,617 bp (Table 2.1).
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Table 2.1. Features of the nine plasmids from seven Caulobacter strains.
Caulobacter AP07
CB4
FWC2
FWC26
Ji-3-8
K31
Root1455
Strain
Genome
5.62
3.86
5.25
4.53
5.26
5.48
5.08
Size (mb)
Plasmids
1
1
1
2
1
2
1
Plasmid
285,650 93,084 248,587 1)
420,617
1)
≥64,657
Size
298,222
233,649
(bp)
2)
2)
45,171
177,878
Number of
268
91
242
1) 279
358
1) 213
≥54
annotated
2) 54
2 172
gene
features

Shintani et al. [4] found that in other Alphaproteobacteria, the average plasmid
length was 218 kb, and the size distribution of the plasmids was trimodal with the size of
the three groups of plasmids averaging 5 kb, 69 kb, and 484 kb, respectively. Our data
are consistent with these groupings except that we did not find any plasmids in the
small size range. Initial alignments of all the plasmids resulted in two groups based on
the parAB and repABC amino acid identities (Fig. 2.1, Supplementary Table C.2 & C.3).
These two groups of plasmids based on the amino acid identities also corresponded to
two different genome size classes. The large-sized group contained plasmids that ranged
in size from 177878 to 420617 bp and included the K31p1, K31p2, AP07, FWC2,
FWC26p1, Ji-3-8 plasmids (Table 2.2). In contrast, the medium-sized group contained
plasmids that ranged in size from 45171 to 93084 bp and included the CB4, Root1455,
FWC26p2 plasmids (Table 2.2).
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Table 2.2. Nucleotide length of the plasmids from various
Caulobacter isolates.
Category

Accession (contig

Plasmid

Size(bp)

CP049200

Ji-3-8

420,617

CP033873

FWC26p1

298,222

number)
Large

Medium

AKKF01000(205,167,003) AP07

285,650*

PEBF01000002

FWC2

248,587

NC_010335

K31p1

233,649

NC_010333

K31p2

177,878

CP013003

CB4

93,084

LMFQ01000010

Root1455

>64,657

CP033874

FWC26p2

45,171

The genes required for maintenance of the plasmid, (the replication, mobility,
and partitioning genes) were located together and in the same order in a conserved
region of each of the medium-sized plasmids (Fig. 2.1). In contrast, the plasmid
maintenance genes were scattered in the large-sized plasmids and gene order was not
conserved (Fig. 2.2). Also, the K31p2 plasmid did not possess a repC gene. RepC is the
replication initiator in other Alphaproteobacteria (23). However, since the K31p1
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plasmid does possess a repC gene, we hypothesized that the RepC protein produced
from this plasmid could initiate the replication of both K31 plasmids.

Figure 2.1. Mauve alignment of the medium-sized plasmids.
The red areas represent regions of nucleotide similarity between
plasmids which includes replication, mobility, and partitioning genes
in the same order in each of the plasmids.
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Figure 2.2. Mauve alignment of the large-sized plasmids.Colored areas are areas of
homology as determine by Mauve. The pink areas contain the repC gene, the
purple areas contain parB gene, and the teal areas contain repAB, mobA, and parA
genes.

Our analyses also provided evidence that a plasmid from the medium-sized
group may have integrated into the K31 genome (Fig. 2.2). The copABCD genes, RND
genes, and czc genes have the same gene order in the K31 genome as they do in the CB4
plasmid (Fig. 2.2). However, the repABC and parAB genes are missing from this region of
the K31 chromosome, perhaps due to selection since their presence might interfere
with the replication of the K31 genome.
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Figure 2.3. Mauve alignment of CB4 plasmid and K31 plasmid. The blue areas
contain the RND genes and CopABCD on CB4 in the same gene order as those in
the K31 genome except that the K31 genome includes a space between the two
CB4 plasmid operons. The red areas contain the czc genes found on the CB4
plasmid in the same gene order as those in the K31 genome.

As indicated above, K31 houses two large plasmids that contain 212 and 172
genes, respectively, and the genome sequences of these two plasmids are present in the
PATRIC database [24] along with that of the CB4 plasmid. Therefore, we were able to
analyze the functional groupings of the proteins that are predicted from the genes on
these plasmids. Many of the K31 plasmid genes code for proteins that do not have
homology to any known protein. However, the genes that code for proteins with
annotated functions could provide considerable metabolic versatility to the K31 host
bacteria (Table 2.3). In contrast, the genes with predicted functions in the smaller CB4
plasmid are all involved in heavy metal resistance. The FWC26p1 plasmid also has
CopABCD and CzcABC operons similar to those depicted in Fig. 2.3. The two sets of
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heavy metal resistance genes are also present in the AP07 and FWC2 genomes but are
not found on the AP07 or FWC2 plasmids.
Table 2.3. Pathway assignments for proteins encoded in the K31p1,
K31p2, and CB4 plasmids.
Pathways

K31p1 K31p2

CB4

Amino Acid Metabolism

+

+

-

Biosynthesis of Polyketides

+

-

-

Biosynthesis of Secondary Metabolites

+

+

-

Carbohydrate Metabolism

+

+

-

Energy Metabolism

+

-

-

Heavy Metal Resistance

-

-

+

Lipid Metabolism

+

+

-

Metabolism of Cofactors and Vitamins

+

+

-

Metabolism of Other Amino Acids

+

+

-

Nucleotide Metabolism

+

-

-

Xenobiotics Degradation and
Metabolism

+

+

-

Characterization of heavy metal resistance conferred by the CB4 plasmid
The C. henricii CB4 plasmid contains nine operons that include 21 heavy metal
resistance genes (Fig. 4). The Cue and Cus operons (2 and 9) have previously been
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shown to be involved in copper efflux and sensing [25,26]. In contrast, Cop operon 5 is
predicted to mediate the homeostasis of copper, with the ability to both import and
export copper ions [27]. The efflux RND, or resistance nodulation division, transporter
genes (Operon 4) code for proteins that form an efflux pump spanning the inner and
outer membrane of bacterium [28]. Copper-translocating P-type ATPases (Operon 1) are
transmembrane proteins with a cation-binding site for catalytic activation and cation
translocation [29]. In addition, the CB4 plasmid contains czc genes (Operons 6, 7, and 8)
that code for proteins involved in resistance to cadmium, zinc, and cobalt.

Figure 2.4. Heavy metal resistance gene operons of the CB4 plasmid.

Copper Resistance
Copper in low concentrations poses no threat to bacteria and actually is required
for growth since some enzymes are only active when they contain a bound copper ion.
However, copper is cytotoxic in higher concentrations [30]. To determine the effect of
the CB4 copper resistance genes, growth of CB4 and C. crescentus NA1000 was
compared in the presence of copper. NA1000 is a well-studied Caulobacter strain that
18

has seven copper resistance genes in its genome. In contrast, the CB4 genome contains
a single annotated copper resistance gene, but as indicated above, there are 21
additional copper resistance genes in the CB4 plasmid. Consistent with the presence of
extra copper resistance genes, CB4 was able to grow in 16 uM CuSO4 while NA1000 did
not grow at this concentration of copper (Table 2.4). The increased copper resistance
observed with CB4 was hypothesized to result from the induction of some or all the
copper resistance genes present in the plasmid.
Table 2.4. Growth assay of CB4 and NA1000
in the presence of copper.
Strain

NA1000

CB4

CuSO4 added

Final OD

none

0.9

16 uM

0.02

none

0.92

16 uM

0.87

To further analyze the effects of copper on the growth of CB4, copper was then
added to cultures of both CB4 and NA1000 at mid-log phase. The 16 um CuSO4 did not
slow the growth rate of CB4, while the NA1000 growth rate slowed to 34% of the
growth rate of the control sample (Fig. 2.4, Supplementary Table B.4).
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Addition of CuSO4 during mid-log phase
1000

100

10

1
NAcu1

NAcu2

NAC1
T0

NAC2

CBC1

T1

T3

T2

CBC2

CBcu1

CBcu2

T4

Figure 2.5. Logarithmic growth analysis of CB4 and NA1000 when CuSO4
was added during mid-log phase. T0 is Klett-Summerson reading at the
time the CuSO4 was added to the experimental tubes. T1, T2, T3, T4 are
number of hours from addition of CuSO4.

To measure the effect of the presence of heavy metals on the expression of the
heavy metal resistance operons, RT-PCR was performed for one gene in each of the nine
presumed heavy metal resistance operons on the plasmid. The operon with the largest
relative change in expression after the addition of copper or silver was the second
operon which codes for the Cu(I)- responsive transcription regulator (CueR) and the
copper-translocating P-type ATPase (CopA) (Table 2.5). CueR with bound copper binds
to the copA promoter and induces expression in E. coli [31]. Similar results with
increased CueR expression were found in E. coli 30 minutes after copper induction (32).
Therefore, we propose that CueR performs a similar function in C. crescentus. In
addition, the expression of all the operons except Operon 8 was increased in the
presence of copper. Similarly, the expression of all of the operons except 4 and 8 were
20

induced by silver, and the expression of all operons except Operon 4 was induced by
zinc. Cross induction of copper resistance genes has been previously shown with both
zinc and silver (33,34).
Table 2.5. Relative expression after the addition of 8 uM of AgNO3, 16 uM of
CuSO4, or 100 uM of ZnCl2.

2-▲▲CT

Operon 1

2

3

4

5

6

7

8

9

2

0.4

1.2

Sample Ag

2.1

21.4 10

0.3

8.3

14

Cu

3.9

64.6 12.7 1.2

20

12.7 4.7

0.5

2.7

Zn

2.1

2.4

1.8

46.7 6.8

2.7

2.2

2.9

0.7

Discussion
Our laboratory’s previous analysis of 12 Caulobacter strains identified three
plasmids based on agarose gel electrophoresis [15]. In contrast, the current study was
more comprehensive since it was based on a nucleotide sequence analysis of more than
70 Caulobacter genomes available in GenBank prior to October 2020. As a result, we
were able to verify the presence of the CB4 plasmid and identify eight additional
plasmids in six different Caulobacter strains. Previous studies [5, 6] had defined three
plasmid groups based on size in the Alphaproteobacteria class: large (~483,939),
medium (~68,377), and small (~4,623). All the Caulobacter plasmids identified in this
study fall in either the medium or large sized groups. No small Caulobacter plasmid has
been identified to date, but our search criteria would not have identified small plasmids
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that might be present in incompletely sequenced Caulobacter genomes. The
Caulobacter plasmids in the large-sized group ranged from 177,878 bp to 420,617 bp.
The medium-sized group ranged from 45,171 bp to 93,084 bp. All the plasmids
contained the required plasmid maintenance genes (repABC and parAB), except for
K31p2 which did not have an annotated repC gene. The RepC protein has been found to
function as the replication initiator protein, and the K31p1 RepC protein could be
further investigated to see if it is functioning as the replication initiator to substitute for
the missing repC gene in K31p2.
A PATRIC protein pathways analysis showed that the K31p1 and K31p2 plasmids
code for proteins that could be involved in a multitude of metabolic pathways,
suggesting that these plasmids provide K31 with the ability to degrade a much wider
variety of environmental compounds. In contrast, aside from the plasmid maintenance
genes, all of the genes with identified functions in the CB4 plasmid are involved in heavy
metal resistance, suggesting that the two types of plasmids appear to serve completely
different functions. However, both plasmids also contain many hypothetical genes
which could have additional valuable functions. The other Caulobacter plasmids were
also found to have some genes of potential importance. For example, the AP07 and Ji-38 plasmids were found to have annotated iron sulfur genes which have been found to
serve as biological sensor-switches in Alphaproteobacteria (35), and the Root 1455
plasmid contains multiple chemotaxis genes that could help this strain locate food
sources.
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All but two of the CB4 heavy metal operons were induced by each of the three
metals tested. This result is consistent with our observation that the CB4 plasmid
confers a high level of copper resistance to its host strain. Operon 2 which includes
genes coding for CueR and a copper translocating P-type ATPase, displayed the largest
relative change in expression induced by copper. Similarly, the E. coli cueR operon has
previously been shown to be induced by both copper and silver and plays an important
role in copper resistance [36,37]. In addition, Operons 6 and 7 were induced by copper
even though they code for cadmium, zinc, and cobalt resistance genes. This result is
consistent with previous studies that showed that copper can induce some, but not all,
czc genes [32].
Since CB4 has both an exopolysaccharide layer, (EPS) (Carter, T and Ely, B,
submitted for publication), and the ability to colonize ferrihydrite (38), we propose that
it could be utilized to clean up wastewater containing heavy metals. The EPS of bacterial
cells has been utilized for bioremediation in heavy metal spills since it binds heavy
metals (39-41), and it causes CB4 cells to clump together and precipitate out of solution.
Furthermore, a strain similar to CB4 was found to colonize ferrihydrite (38), an iron
hydroxide used in the removal of heavy metal ions in wastewater (42). Thus, CB4 with
its EPS, heavy metal resistance genes, and ability to colonize ferrihydrite may facilitate
heavy metal wastewater cleanup.

23

CHAPTER 3
ELECTROPORATION INEFFICIENCY IN CAULOBACTER HENRICII CB4

Carter, T. Submitted to All Results Journal:Biol, 01/20/2021
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Introduction
Caulobacter crescentus is a gram-negative Alphaproteobacterium that divides
asymmetrically, resulting in a stalked cell and a motile swarmer cell (1). In addition, it
has a well-developed system of genetics (2) that makes it an excellent model system for
the study of cellular differentiation, asymmetric division, and cell cycle transition (3,4).
Unlike the C. crescentus strains, the wild type strain C. henricii CB4 has received little
attention even though it houses a 93 kb plasmid, which contains 21 heavy metal
resistance genes (5,7, Carter and Ely submitted). CB4 was isolated from pond water in
1959 displaying a vibrioid morphology and forming bright yellow colonies (6). The
nucleotide sequence of the CB4 genome and its plasmid has been determined (7), and
an analysis of the results indicated that the plasmid contains genes involved in
conjugation so it may be able to transfer itself to other strains of Caulobacter.
To facilitate a test for conjugal transfer, we attempted to add a kanamycin
resistance gene to the plasmid by transposon mutagenesis. Christen et al. (8)
established the essential genome of Caulobacter crescentus utilizing transposon
mutagenesis from the pXylTn5 plasmid containing a xylose inducible Tn5 transposase.
The basic approach was to transfer the plasmid into C. crescentus from E. coli with
selection for the kanamycin resistance conferred by the transposon. This technique
proved to be an excellent way to get large numbers of C. crescentus mutants (8). We
planned to use the pXylTn5 plasmid to transpose the gene for kanamycin resistance into
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the CB4 plasmid to provide a marker to select for the transfer of the CB4 plasmid
transfer into a C. crescentus strain.
A second approach was to modify the pBR322 plasmid so that it contained
sequence homology to a copper ATPase gene (copA) located on the CB4 plasmid. The
resulting pBR322-copA plasmid contained the beginning and ending sequences of the
copA gene flanking a tetracycline antibiotic gene. Since this plasmid is not stable in
Caulobacters, once it was transferred to CB4, a homologous recombination event would
be needed to disrupt the plasmid copper-translocating P-type ATPase gene and confer
tetracycline resistance to the host cell.
Preliminary experiments employing standard electroporation or conjugation
techniques did not produce any antibiotic resistant CB4 colonies even though control
experiments with C. crescentus CB15 were successful. Although conjugation
experiments generally work well, Caulobacters are difficult to electroporate due to their
paracrystalline protein surface layer, or S-layer (9). Visual and centrifuge assays have
shown the CB4 S-layer to be thicker than the CB15 S-layer and could be the reason for
the unsuccessful electroporation. Alternatively, CB4 could house an exopolysaccharide
layer, or EPS. In CB15 and CB2, the EPS is a tetrasaccharide capsule which could not be
easily removed by washing (10).
The S-layer is comprised of a 98 kDa RsaA protein that assembles into six subunit
hexagons that combine with other hexagon subunits to create a two-dimensional
hexagonal array (11). Ca2+ is required for the proper crystallization of the RsaA protein,
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and the removal of Ca2+ has been shown to disrupt the crystallization (12). S-layers are
involved in cellular protection and stabilization (13). In Caulobacter, the S-layer is
hypothesized to be involved in both ion sensing and allowing Caulobacter to live in
calcium deficient environments (14). S-layer deficient CB2 and CB15 Caulobacter strains
were found to have a 10 times higher electroporation efficiency compared to their Slayer containing counterparts (9).
Various techniques to destabilize the S-layer have been described. For example,
a LiCl2 wash has been shown to decrease the calcium levels and destabilize the S-layer
and increase electroporation efficiency (15). Increasing the resistance utilized during
electroporation has been demonstrated to increase electroporation efficiency in S-layer
Caulobacter strains as well (9). Unrelated to the S-layer, it has been shown that growing
the bacterium in glycine can improve electroporation efficiency in various bacteria (16,
17). Finally, unmethylated plasmids were shown to incorporate at a higher frequency
than methylated plasmids (18). Since our initial attempts to move plasmids into CB4
were not successful, these techniques were used in combination and independently in
an attempt to improve electroporation efficiency in CB4 with no success.
Methods
Plasmids
The pXylTn5 plasmid (8) was obtained from Dr. Beat Christen (ETH Zurich). To
construct the pBR322-copA plasmid (Figure 3.1), primers for the two flanking regions of
the copA CB4 plasmid gene were designed with restriction sites added on the end of the
27

primers and used to amplify the beginning and end regions of the copA gene with PCR
(Supplementary Table C.1). Concurrently, the pBR322 plasmid was cut with BsmI and
AvaI (Fig. 3.1) and the resulting fragments were separated by agarose gel
electrophoresis. The larger section of the cleaved pBR322 plasmid was extracted,
purified, and ligated to the copA BsmF2 and AvaR2 PCR fragment. The ligated plasmid
was transformed into E. coli S17 (19) and then plated on LB (20) tetracycline (1 ug/ml)
plates. A tetracycline resistant colony was purified, grown overnight in LB, and the
pBR322 plasmid containing the distal part of the copA gene was isolated. The plasmid
was digested with BsmI and AvaI to confirm the presence of the copA gene fragment.
The newly constructed plasmid was then digested with EcoR1 and ClaI, purified as
above, and ligated with the copA EcoF1 and ClaR1 PCR fragment. After the ligated
construct was transformed into E. coli, purified and re-isolated, the proper configuration
of the pBR322-copA plasmid was confirmed by PCR using the EcoF1 and AvaR2 primers.
The pBR322-copA plasmid also was transformed into a DCM-/DAM- E.coli strain (ZYMO
mix n go), and both the methylated and unmethylated forms of pBR322-copA were used
for the remainder of the experiments.
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EcoRI

pBR322-copA
5.4kB

Figure 3.1. Structure of pBR322-copA plasmid.
Two ~250 bp segments from the CB4 plasmid
copA gene were ligated in at EcoRI/ClaI and
BsmI/AvaI cut sites.

Electroporation
To prepare electrocompetent cells, CB4 and NA1000 were grown in 100 mL PYE
(21) to mid-log phase. The samples were divided into 50 mL centrifuge tubes and spun
at 7000 x g for 5 minutes, and the resulting cell pellets were resuspended in 20 mL of
sterile deionized water. The samples were then spun and resuspended as before. The
final pellets were resuspended in 2 mL of 10% glycerol, spun at 4000 x g for 5 minutes,
and resuspended in 400 ul of 10% glycerol. Finally, 200 ul aliquots were prepared with
half used right away and half stored in the -70°C freezer.
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For electroporation, 40 ul of the CB4 electrocompetent cells were placed in a 0.5
mL tube in, and 2 ul plasmid DNA was added. Subsequently, 40 ul of the CB4/plasmid
mixture was placed in a 0.2cm Bio Rad (Hercules, CA) Gene Pulser cuvette the and
subjected to a 2.5-kV shock with the capacitor set at 25 uF (microfarad) and the
resistance at 200 ohms in a Bio Rad Gene Pulser electroporator. With a 0.2 cm cuvette
gap, a 4.5 to 5 msec time constraint was expected at 200 ohms. After the shock, the
contents of the cuvette were mixed with 1 ml PYE, transferred to a sterile test tube, and
incubated at 30°C for 2 hours before 200 ul of each sample was plated on PYE plates
containing the appropriate antibiotic. When using the pXylTn5 plasmid, the plates also
contained 100 ul of a 10% xylose solution to induce transposition.
Conjugation procedure
The E. coli BC1490 which houses the pXylTn5 plasmid and CB4 cultures were
grown overnight in LB or PYE medium, respectively. To initiate conjugation, one mL of
the CB4 culture was gently mixed with 0.1 mL of the E. coli BC1490 culture. After the
mixture was filtered through a Millipore HA 0.45 uM filter, the filter was then placed on
a PYE plate and incubated overnight at room temperature. After the incubation, the
filter was placed in sterile test tube with 500 uL PYE, and the bacteria were resuspended
by vortexing. Subsequently 200 uL of the bacteria suspension was plated on each of two
PYE plates containing the appropriate antibiotic to select for the presence of the
plasmid and nalidixic acid (20 ug/mL) to select against the E. coli donor strain. Each
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mating experiment was performed twice for replication of results. Plates were then
incubated at 30°C for 2-3 days until colonies appeared.
Results
The pBR322-copA plasmid contains two sections of the copper-translocating Ptype ATPase copA gene (approximately 250 bp each) that flank a tetracycline gene and
are identical to the corresponding regions of the CB4 plasmid (Fig. 1). Since the pBR322copA plasmid cannot replicate in Caulobacter, homologous recombination would be
needed for the host bacterium to acquire tetracycline resistance after the introduction
of the plasmid. Initially, the standard electroporation procedure was used in an
unsuccessful attempt to get the plasmid into CB4. Of note, CB4 tended to aggregate into
clumps that were difficult to disperse during the preparation of the electrocompetent
cells, in comparison to NA1000 where the bacteria goes back into solution from the
pelleted state without much agitation. CB4 gave a time constraint of 3.4-3.6 msec at the
standard electroporation settings compared to the 4.6-4.8 msec obtained with other
Caulobacter strains. Each experiment was run in duplicate and then it was replicated 4
separate times. No CB4 transformants were obtained from any of these experiments.
To further investigate, we attempted to transform the pXylTn5 plasmid into both
CB4 and NA1000. The standard protocol was followed and approximately 100
transformants were obtained with NA1000, and no transformants were obtained with
CB4. The experiment was replicated with the same results. Since the standard
procedures were not working, we decided to alter both the variables involved in the
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preparation of the electrocompetent CB4 cells and the electroporation procedure itself
as described below.
Varying resistance during electroporation
Gilchrist and Smit (9) demonstrated that increasing the resistance from 200 or
400 to 600 or 800 ohms increased the number of transformants for S-layer containing
Caulobacters. Also, Spath et al. (18) showed that the use of an unmethylated plasmid
can increase transformation efficiency. Therefore, CB4 electrocompetent cells were
prepared according to standard protocol and electroporation experiments were
performed at 200, 400, 600, and 800 ohms. For each level of resistance, transformations
with both a methylated and an unmethylated plasmid were attempted in duplicate, and
the time constraints did increase in relation to the increase in resistance. Although
increasing the resistance had previously increased the number of transformants in Slayer containing Caulobacters (9), no transformants were observed for any of the 16
samples. As a control an additional aliquot was plated on antibiotic-free control plate to
verify bacterial viability.
LiCl2 Wash
A LiCl2 wash has been shown to disrupt the Ca2+ component of the S-layer and
increase electroporation efficiency (15). Therefore, a LiCl2 wash was added after the
initial pelleting of CB4. The pelleted CB4 cells were resuspended in 5 mL of 5M LiCl2 and
held on ice for 30 minutes, pelleted, then resuspended in 5 M LiCl 2 and held on ice for
an additional 30 minutes. The LiCl2 procedure called for the use of SMEB as the
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resuspension and electroporation buffer instead of using the 10% glycerol as called for
by the standard procedure. Using the SMEB after the LiCl 2 resulted in a 0.1 msec time
constraint and a “pop” of the cuvette when a spark was emitted. One cause of this is
can be a high salt concentration. To bypass this problem, a 10% glycerol solution was
used during the wash and final preparation of the electrocompetent cells. This modified
procedure resulted in the expected time constraints at the 200 and 400 ohms
resistance. Again, the experiment was performed with both a methylated and
unmethylated plasmid at both 200 and 400 ohms, and no transformants were obtained.
To confirm cell viability, 400 ul of one of the LiCl 2 washed electroporation samples was
plated on a PYE with no antibiotics and cell growth occurred at the expected rate.
Glycine Growth Media
In other bacteria, adding glycine to the growth medium has been shown to
increase electroporation efficiency (16,17). CB4 was unable to grow in the previously
established 1% glycine concentration which had been shown to increase electroporation
efficiency. The highest concentration of glycine that allowed CB4 to grow was 0.1%, and
electrocompetent cells were prepared from CB4 cells grown in the presence of 0.1%
glycine. For electroporation, both the methylated and unmethylated pBR322-cop
plasmids were used at 200 and 400 ohms resistance. The experiment was performed in
duplicate and the expected time constraints were obtained, yet none of the runs
resulted in any transformants.
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EPS
Caulobacter can possess an exopolysaccharide, or EPS layer than acts as another
physical barrier to the cell (10). Electron microscopy showed that an EPS layer was
present on CB4 cells, as did the clumping of cells during the cell preparation procedure
(Fig. 3.2). Growing bacteria in the presence of 0.7 mM EDTA has been shown to disrupt
the EPS and increase electroporation efficiency in other gram-negative bacteria (22), but
CB4 did not grow at that concentration of EDTA. Caulobacter requires 0.5 mM Ca++ for
optimal growth (23) and is sensitive to calcium levels when the S-layer is disrupted (14).
CB4 was able to grow at 0.3 mM and 0.4 mM, but not 0.7 mM, EDTA. Therefore, 30 mL
cultured of CB4 with 0.3 mM or 0.4 mM EDTA were grown to 30 Kletts, spun down, and
washed with 10% glycerol four times. The cells were then pelleted and resuspended in
160 ul of 10% glycerol. Subsequently, 40 ul of the electrocompetent cells were mixed
with 1 ul of methylated or unmethylated pBR322-copA and electroporated with the
standard procedure. All runs resulted in zero transformants. A control experiment with
electrocompetent cells created from CB4 grown in both PYE and PYE with 0.4 mM EDTA
resulted in 1.25x105 CFU/mL of the PYE-grown CB4 competent cells, and no colonies
were observed when 20 ul of the EDTA-grown CB4 competent cells were spread on PYE
plates. Therefore, we concluded that growth in EDTA lowered the survival rate during
the preparation of electrocompetent cells to the point that no surviving cells were
present.
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(a)

(b)
Figure 3.2. Electron microscope images of
C. henricii CB4. (a) The EPS layer surrounding
the CB4 bacterium is visible as a halo.
(b) A clump of CB4 cells.

35

Table 3.1. Description of altered variables to increase electroporation efficiency.

Increased
Resistance
Unmethylated
Plasmids
LiCl2 Wash
Glycine Growth
Media
EPS
Disruption

Description

Source

Increasing the resistance to 600 or 800 ohms has been
shown to increase electroporation efficiency in
Caulobacters with S-layers.
Unmethylated plasmids (DCM-/DAM-) have been shown
to increase electroporation efficiency.

[9]

LiCl2 wash used to disrupt Ca2+ and RsaA interaction and
destabilize the S-Layer
Glycine added to growth media has been shown to
increase electroporation efficiency.
Bacteria grown in the presence of EDTA has been shown
to disrupt the exopolysaccharide layer.

[18]
[15]
[16,17]
[22]

Conjugation experiments
Conjugation can also be used to transfer a plasmid from E. coli to Caulobacter
(24). Therefore, conjugation experiments were carried out using the same NA1000 and
CB4 bacteria strains with E. coli BC1490 which houses the pXylTn5 plasmid.
Approximately 400 colonies were obtained with NA1000 as a recipient and no colonies
were obtained with CB4 as a recipient. This experiment was repeated with C. crescentus
strain SC1004 and CB4 with similar results (Fig. 3.3). Alternatively, conjugation
experiments were carried out with CB4 and E. coli HB101 which houses the pRK290
plasmid. The pRK290 plasmid houses a RK2 replicon which has been shown to be stable
in Caulobacter (25), but again, no colonies were obtained from the conjugation with
CB4.
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(a)

(b)

Figure 3.3 Conjugation results with CB4 and BC1490 (1a), and
C. crescentus SC1004 and BC1490 (1b).

Discussion
Electroporation is a useful technique for the introduction of foreign DNA into a
bacterium. Previous work has demonstrated that getting DNA into C. crescentus
electroporation is more difficult due to its S-layer (9). The S-layer is a crystalline layer
consisting of RsaA protein subunits and Ca2+ ions. Gilchrist and Smit (9) demonstrated
that increasing the resistance increased electroporation efficiency in S-layer containing
C. crescentus strains. However, our use of this procedure did not result in any CB4
transformants. Other researchers increased bacterial electroporation efficiency by using
unmethylated plasmids (17), or growth in glycine (16, 17). However, neither of these
procedures was successful with CB4. Also, a LiCl 2 wash during the preparation of
electrocompetent cells has been shown to disrupt the S-layer by removing the Ca2+ ions
(15), but this technique also did not result in any CB4 transformants. In addition, we
were unable to transfer plasmids into CB4 using standard conjugation techniques.
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It is possible that the CB4 S-layer is thick enough so that these techniques do not
disrupt it sufficiently to allow for the uptake of foreign DNA. In addition, CB4 also has an
extracellular polysaccharide (EPS) layer that may block DNA uptake as well. It also is
possible that CB4 produces an endonuclease that cleaves extracellular DNA during the
electroporation procedure. However, the inability to transfer a plasmid via conjugation
where exposure to an endonuclease would not occur indicates that the primary issue is
some type of external barrier(s) that prevents both conjugation and electroporation
from occurring. Further evidence for this barrier is that CB4 tends to form clumps of
cells during growth (Fig. 3.2), and CB4 cell pellets are difficult to resuspend after
centrifugation. Thus, CB4 cells tend to stick to each other in ways that are not observed
with C. crescentus cells. The role of calcium in S-layer and EPS disruption was also found
to decrease cell viability after electroporation. This creates a difficult situation in which
disrupting the EPS and S-layer to allow foreign DNA to enter decreases cell viability.
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CHAPTER 4
FROM SARS-COV2 TO BLOOD CLOTS, A FURIN CLEAVED S1 BUILDUP

Carter, T. To be submitted to Viral Immunology

39

Abstract
SARS-CoV2 has greatly affected the entire world for the majority of 2020. Many
laboratories have been hard at work on developing treatments and vaccines, yet to date
no therapeutic approach has been able to greatly reduce the mortality rate. Many
patients, especially the young have exhibited mild symptoms or no symptoms at all. In
contrast, we hypothesize that in older patients with fewer ACE2 receptors, the furincleaved S1 protein binds to most of the available ACE2 receptors, resulting in a cellular
build-up of Angiotensin II. This build-up then leads to a cascade of effects that ultimately
results in numerous blood clots. Recently several studies have shown that drugs that
target the early stages of this SARS-CoV2 molecular cascade pathway are able to lower
the mortality rate currently occurring with this deadly virus.
Mini Review
Introduction (background)
SARS-CoV2 has infected over 12 million Americans by late November 2020 (1),
and more than 250,000 Americans infected have died due to COVID-19. Even with
vaccines on the horizon, a successful reduction in mortality would have great benefit to
society. The molecular mechanisms that SARS-CoV2 utilizes are understood well enough
to know which molecular interactions to target with therapeutics. As more information
is collected on deceased COVID-19 patients, a commonality of blood clots is starting to
surface suggesting that blood clots could be the primary cause of COVID-19 deaths (2-4).
Therefore, preventing the blood clots, or the molecular cascade that leads to the blood
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clots, could result in a decreased mortality rate. This review will detail how the SARSCoV2 virus could be inducing blood clotting in patients and suggest that several drugs
that have been shown to reduce COVID-19 mortality may be disrupting this cascade.
S1 build up
During the initial infection, the SARS-CoV2 virus, like SARS-CoV1 (5), binds to the
ACE2 (Angiotensin converting enzyme 2) receptor, and the viral spike protein is cleaved
by TMPRSS2. The S2 portion of the spike protein then allows membrane fusion and viral
entry (6). SARS-CoV2 has a higher binding affinity to ACE2 than SARS-CoV1 so it is more
efficient at this initial stage of infection (7). Another difference between SARS-CoV1 and
SARS-CoV2 is the PPC/furin cleavage site located between the S1 and S2 portions of the
spike protein. However, this difference does not seem to enhance viral entry into the
cell (7). The majority of human proprotein convertases (PPC), such as PCSK3 (furin), are
found in the trans golgi network (8). As a result, the S protein is processed almost
entirely into S1 and S2 during biosynthesis (7,9). For example, in SARS-CoV2 infected
Vero E6 cells, 45% of the spikes found on a SARS-CoV2 virion were cleaved at the S1/S2
site, and in Calu-3 cells 73% of the spikes were cleaved at the S1/S2 site (60). MERS,
another coronavirus that houses a furin cleavage site between S1/S2 was also found to
be processed by PPC in MERS-CoV infected cells and MERS- S transfected cells, yet the
inhibition of the PPC did not affect MERS infectivity (10). Furthermore, the cleaved S1
protein is likely to be protected from degradation due to the interaction of SARS-CoV2’s
ORF10 with the cullin-2 (CUL2) RING E3 ligase complex (11) which would protect the
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cleaved S1 protein from ubiquitin targeted degradation (12). The accumulated S1
protein would be released into the extracellular environment during cellular lysis and
could bind to the ACE2 receptors on the surface of nearby cells. The isolated S1 protein
has been shown to bind soluble ACE2 (13,14), and Zhao et al. (15) showed that tagged
S1 had significant and consistent association with human ACE2. This S1 binding would
lead to a cascade of molecular interactions that would result in blood clots as will be
detailed below.
Angiotensin converting enzyme 2 (ACE2)
ACE2’s main biological function is the conversion of Angiotensin II (AngII) into
Angiotensin-(1-7) (16) as part of the Renin-Angiotensin System, or RAS (17). The RAS is a
molecular cascade pathway that is involved in hypertension and other cardiovascular
disorders (18). Angiotensin II binds to ATR1 (angiotensin type 1 receptor) and ATR2
(angiotensin type 2 receptor) (19,20). AngII mainly acts by binding to ATR1, while the
ACE2 product Ang-(1-7) binds to the Mas receptor (21), which promotes a counterbalancing pathway to AngII/ATR1 (22). The viral bound ACE2, or the hypothesized
S1/ACE2 complex would result in higher concentrations of AngII, and lower levels of
Ang-(1-7) since ACE2 would not be available to convert AngII into Ang-(1-7). A study by
Wu et al. (23) showed that the AngII plasma levels were higher than normal in most
COVID-19 patients and in all of the critically ill COVID-19 patients. In addition, univariate
analysis showed a positive correlation between plasma AngII concentration and COVID19 severity across 82 non-hypertensive patients. This altered balance would disrupt RAS
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as described above. In addition, based on autopsy results of multiple blood clots, and
increased numbers of megakaryocytes, it seems that IL-6, a cytokine whose expression
has been shown to be induced by AngII (24), may play a vital role in blood clotting.
AngII and IL-6 by way of ATR1
Since an ATR1 inhibitor blocks AngII induced IL-6 production, Clancy et al. (25)
concluded that AngII induces the production of IL-6 through ATR1, and IL-6 is essential
for the physiological changes induced by AngII (26). In the kidney, AngII has been shown
to induce IL-6 production in both human and rat models (27). Furthermore, IL-6 is a
downstream byproduct of AngII binding to ATR1, since a blocked ATR1 receptor resulted
in lower concentrations of IL-6 (28). In contrast, Ang-(1-7) has the opposite effect and
attenuates IL-6 expression (29). Thus, an altered balance of AngII and Ang-(1-7) could
lead to high levels of IL-6, and since IL-6 has been shown to increase the expression of
ATR1 a feed forward loop would develop to further increase IL-6 levels (28). Evidence
that this feed forward loop occurs has been found in critically ill SARS-CoV2 patients
who have up to 10 times normal IL-6 levels (30), and these high levels would play a vital
role in the molecular cascade that results in blood clots.
Megakaryocytes
Autopsy results in New York left scientists surprised when they found platelet
rich thrombi and an increased number of megakaryocytes in the lungs, heart and
kidneys of the deceased (2). Megakaryocytes are highly specialized precursor cells that
ultimately result in the release of platelets (31). The majority of megakaryocytes are
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found in bone marrow, but it is estimated 20-50% of the mature megakaryocyte
population enters the blood and ultimately resides in the lungs (32). Two factors would
result in the increased concentrations of megakaryocytes seen in the autopsies: 1)
increased stromal cell-derived factor 1 (SDF-1) levels would result from AngII binding to
ATR1, and increased SDF-1 levels are involved in megakaryocyte localization and platelet
formation (33-36); and 2) increased thrombopoietin (TPO) levels also would occur due
to the high levels of IL-6 (37). Thrombopoietin (TPO) is involved in the proliferation,
differentiation, and maturation of megakaryocytes (38), and IL-6 has been found to
directly increase the mRNA expression levels of TPO in HepG2 cell cultures and also
increase TPO plasma levels in human cancer patients (37). Thus, increased SDF-1 and/or
increased TPO could lead to increased megakaryocyte migration and maturation,
resulting in an increased number of platelet-forming megakaryocytes as seen in the
autopsy reports.
TF platelets and blood clots
Tissue factor (TF) is a transmembrane receptor involved in blood coagulation
(39), and TF platelets are associated with morbidity in severe COVID patients (40).
Neutrophils from COVID-19 patients have high TF expression and produce functionally
active TF, through neutrophil extracellular traps (NETs) (41). NETs are composed of
chromatin and antimicrobial proteins and have been found to play a role in thrombin
generation (42). High NET levels occur in many COVID patients (43), and neutrophils are
likely to be present in higher numbers since AngII recruits neutrophils in vivo (44). AngII
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also stimulates platelets to express TF in a rat model (45), and it can induce platelet
shape change, which is required for platelet aggregation (46). In autopsy patients in
Houston, the platelets from Megakaryocytes were found to entrap numerous
neutrophils within small vessels (47), which would lead to blood clots. Taken together,
these factors could account for the severity of blood clotting in COVID-19 patients.
Higher mortality rate in elderly and males could be attributed to lower Ace2
expression thus leading to more blood clots
It has been hypothesized that an increase in ACE2 receptors would lead to an
increased severity in COVID disease, yet the groups with the highest levels of ACE2
receptors: females and the young are least at risk (48). This fits in with the hypothesis
that the cleaved S1 protein is blocking the majority of the biologically active ACE2
receptors in severely ill patients. In contrast, individuals with more ACE2 receptors
might be able to avoid the cascading effects of the AngII buildup since it would be more
difficult to block most of the ACE2 receptors. Although the virus would find easier cell
entry if there were more ACE2 receptors, more receptors per cell also could result in
individual cells binding multiple viruses and fewer cells being infected. Either way, the
severe illness present in some SARS-CoV2 cases could be avoided.
Severity blood markers: IL-6 and Syndecan-1
A new study by Wang et al. (49) analyzing the blood of 12 COVID-19 patients
found that IL-6 and Syndecan 1 levels were higher in the severe persistent group
compared to the recovering group. Syndecan 1 is part of a family of cell surface heparan
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sulfate proteoglycans involved in inflammatory and disease responses (50). The higher
levels of both IL-6 and Syndecan 1 can be attributed to the higher AngII levels in the
cellular environment. As discussed above, high AngII levels increase IL-6 levels, so higher
IL-6 levels would be expected in patients with severe COVID-19. Furthermore, Wang et
al. (51), showed that AngII increases mRNA expression of Syndecan 1, increases cellsurface Syndecan 1, and speeds up Syndecan 1 shedding in murine macrophages.
Another murine study (52) showed that in Syndecan 1 knockout mice, cardiac
dysfunction during AngII induced hypertension was reduced. Thus, high Syndecan 1
levels contribute to hypertension-induced cardiac dysfunction. Although IL-6 and
Syndecan 1 can be increased by many pathways, their higher levels in the severe COVID19 patients would be the expected result of increased AngII levels.
Blocking the AngII-induced cascade
Angiotensin II receptor blockers or ARBs have been shown to greatly reduce Ddimer, a biomarker of blood clots, in elderly COVID-19 patients compared to non ARBusers (53). Losartan would be a prime candidate for treatment of COVID-19-induced
clots in elderly patients and multiple studies have demonstrated its safety profile
(54,55). In addition, the University of Minnesota is currently housing an ongoing
Losartan clinical trial (NCT04312009) for hospitalized COVID-19 patients.
Baricitinib, a JAK inhibitor, was recently found to have a 71% mortality benefit in
83 COVID-19 patients (56). The JAK-STAT pathway has been shown to mediate
AngII/ATR1 triggered gene transcription. AngII has been shown to elicit JAK pathways in
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a G protein-dependent and -independent fashion (57). Furthermore, a rheumatoid
arthritis study demonstrated that Baricitinib has an acceptable safety profile (58).
Soluble ACE2 receptor is another viable treatment option. One study showed a
decrease in IL-6 and AngII levels, with an increase in Ang-(1-7) after soluble human
recombinant ACE2 (shrACE2) was administered through IV (59). Ang-(1-7) is another
potential treatment option, based on its counter-effect to AngII/ATR1. Currently a
clinical trial (NCT04332666) is underway to determine its efficacy.
Discussion
Blood clots are a common occurrence in severe COVID patients (2). A recent
study looking at the blood work of COVID patients saw a significant increase in IL-6 and
Syndecan-1 levels between the recovering and severe patients (49). We hypothesize
that the cause of these symptoms and blood markers is from the buildup of Angiotensin
II (23) caused by the Furin cleaved S1 protein of the SARS-CoV2 virus binding to the
ACE2 receptor (7,9), and blocking the conversion of Angiotensin II to Angiotensin-(1-7).
This buildup of AngII disrupts the Renin-Angiotensin System and leads to a molecular
cascade that results in TF-platelet blood clots (45,46). In addition, this hypothesis
accounts for the higher mortality rate in the elderly population as data has shown they
have lower ACE2 levels than young individuals (48). Targeting this molecular cascade
and the S1 protein could provide valuable therapeutic approaches that would help
severe COVID-19 patients. Current clinical trials and research results have proven this to
be true (53,56,59). The ongoing Ang-(1-7) clinical trial (NCT04332666) and Losartan
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clinical trial (NCT04312009) should have promising results as well. Although blocking
ATR1 or inhibiting JAK provides relief due to the increased AngII/ATR1 binding, there is
still the problem of lack of Ang-(1-7). Losartan and Baricitinib will improve clotting
conditions, but the hypothetical best combination to overcome lack of ACE2 would be
either drug in combination with Ang-(1-7), or soluble ACE2.
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CHAPTER 5
CONCLUSION
Many people choose to focus on one particular subject during their time as a PhD
student, yet I felt expanding my knowledge base to as many topics as I could learn
would best prepare me for my future. I have always tried to expand myself in everything
I try, from sports to social groups to academic topics. This perhaps could be a result of
living with OCD and PTSD and living day to day with my brain trying to focus and obsess
on one topic and attempting to push back and actively expand in all areas. During the
times of my many surgeries, I read every journal article I could on a variety of topics.
This led to an interest in plants, which resulted in me devising a molecular way to
confirm the speciation of two Shortia plants (1). In Spring 2020 when SARS-CoV2 forced
the in-person closure of the University, I read as many articles on the virus as I could.
This, along with my previous virion-host knowledge paid off in my creation of the SARSCoV2 S1 buildup hypothesis found in chapter 4. My path to this point in my career has
not been standard by any means. I do believe though, that without all my setbacks I
would not be the scientist I am today.
Role of naturally occurring Caulobacter Plasmids
Although the genomes of the Caulobacter genus had been well studied (2,3), not
much was known about the plasmids that were present in many strains. Bioinformatic
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searches helped me identify and classify a total of nine plasmids located in seven
Caulobacter strains. The plasmids all contained the essential genes needed for plasmid
replication, partitioning, and mobility: repABC, parAB, or mobAB, except for one plasmid
K31p2 which did not have a repC gene to code for the replication initiator protein. This
observation could be investigated further to determine if the K31p1 RepC protein is
acting as the replication initiator protein for both the K31p1 and K31p2 plasmids since
they are housed in the same bacterium. The nine Caulobacter plasmids that we
identified were then sorted into two groups, based both on size and the nucleotide
sequence of the essential plasmid genes that corresponded to the medium and large
plasmid groups identified in a previous Alphaproteobacterial study (4).
A PATRIC protein pathway analysis of the K31p1, K31p2, and CB4 plasmids was
used to identify the genes on each of the plasmids that correspond to genes with known
functions. This analysis showed that the K31p1 and K31p2 plasmids contain genes that
participate in various metabolic pathways such as amino acid, lipid, carbohydrate, and
xenobiotic metabolism but neither plasmid contained genes related to heavy metal
resistance. In contrast, the CB4 plasmid contains 21 heavy metal resistance genes and
no genes known to be involved in metabolic pathways. Because of the presence of these
heavy metal resistance genes, the CB4 plasmid was selected for further analyses. Since
most of these genes were annotated as copper resistance genes, we tested CB4 for
growth in CuSO4 and demonstrated that concentrations up to 16 uM CuSO4 did not
disrupt the growth of the CB4 strain even though this concentration of CuSO 4 totally
inhibited the growth of the standard laboratory strain C. crescentus NA1000. In addition,
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quantitative PCR results showed that CuSO4 induced the expression of 8 of the 9 heavy
metal resistance operons.
The ability of CB4 to live in high copper environments could have an important
environmental impact since CB4 has been found to colonize ferrihydrite by attaching to
it via its sticky holdfast (5). Ferrihydrite is an iron precursor found in soil and has been
used in industrial wastewater clean ups (6). Ferrihydrite binds Сd2+, Cu2+, and Zn2+, which
are metals that are pumped out of the cell by the czc, cop, cus, and cue systems present
on the CB4 plasmid. CB4 also possess an exopolysacchride layer, or EPS. Bacterial EPS
have been used to pull heavy metals out of wastewater spills (7,8). Therefore, the
addition of both CB4 and ferrihydrite to wastewater could be beneficial for removal of
the metal ions. One of the problems with ferrihydrite is the difficulty of getting it out of
the wastewater solution after it has bound the heavy metal ions. CB4 bound to
ferrihydrite could be added to the wastewater to bind the contaminating metal ions.
Since CB4 cells tend to form clumps due to its EPS and sink to the bottom of a container,
the CB4/ferrihydrite/metal ion complexes then would gradually settle to the bottom of
the container and the purified wastewater could be removed from the top of the
container. The combination of CB4’s heavy metal resistance, EPS, and ability to colonize
ferrihydrite could prove beneficial to future wastewater cleanup practices.
Electroporation Inefficiency in Caulobacter henricii CB4
C. henricii CB4 like other S-layer containing Caulobacter strains has proven
difficult to electroporate. Gilchrist and Smit (9) showed that mutant S-layer deficient C.
51

crescentus CB2 had 10 times the electroporation efficiency in relation to the wildtype
CB2. Electroporation done simultaneously with CB4 and its close relative C. crescentus
CB15 resulted in 100 transformants/plate with CB15, but none with CB4.
Experiments were then designed utilizing electroporation conditions found to be
beneficial in increasing electroporation efficiency. For example, increasing the resistance
of the electroporator from 200 ohms to 400, 600, or 800 ohms has previously been
shown to increase electroporation efficiency in S-layer containing Caulobacter strains
(9). With CB4, the increased resistance settings did not result in any transformants.
Similarly, a LiCl2 wash disrupts the Ca2+ ions which stabilize the S-layer and has been
shown to increase electroporation efficiency (10). Again, the LiCl 2 wash with CB4 did not
result in any transformants. The addition of glycine to the growth media of bacteria has
been shown to increase electroporation but did not result in any transformants with
CB4 (11,12).
Since targeting the S-layer did not yield transformants and electron microscopy
images of CB4 showed the presence of an exopolysaccharide (EPS) layer which can
create a physical barrier around the bacterium (13), we changed our focus to the EPS
layer. EDTA has been shown to disrupt the EPS in bacteria and increase electroporation
efficiency (14). The addition of EDTA in various concentrations did not result in any
electroporation transformants in CB4. Disrupting the S-layer, or EPS through chelators is
difficult as Caulobacter is sensitive to low calcium levels when its S-layer is disrupted
(15). This sensitivity creates a situation where the cell viability is decreased to low levels
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when the S-layer or EPS are disrupted, and calcium levels are low. This dynamic
potentially counters any benefit in electroporation efficiency brought on by the S-layer
or EPS disruption.
SARS-CoV 2 and blood clots
Autopsies have been conducted to determine what factors lead to the death of
COVID patients. The most surprising finding of the first autopsy studies was the
presence blood clots in major organs, and an increase in the number of megakaryocytes
present in the lungs, heart, and kidneys of the deceased patients (16-18). After
reviewing as much of the published data as I could find, I proposed that the furincleaved S1 fragment of the spike protein could bind to most of the available ACE2 in the
cellular environment. Since ACE2 is required to convert Angiotensin II (AngII) to ANG1-7,
blocking ACE2 could lead to a buildup of Angiotensin II (AngII). Angiotensin II is part of
RAS, or Renin Angiotensin System (19). Its main target is the ATR1 receptor, and its
downstream effects detailed in Chapter 4 would contribute to the molecular cascade
that causes the TF-platelet blood clots.
The identification of this molecular cascade can help scientists better understand
the experimental results for the studies of Losartan, Baricitinib, and soluble ACE2 in
severe COVID-19 patients (20-22). Losartan was shown to decrease D-dimer, a
biomarker for blood clots in elderly COVID-19 patients (20). Baicitinib, a JAK inhibitor,
had an 81% mortality benefit in severe COVID-19 patients (21). Soluble ACE2 decreased
IL-6 levels in a severe COVID-19 case (22). Soluble ACE2-fC would seem to be the most
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viable option for treatment. This drug would not only bind the S1, and covert AngII into
Ang-(1-7), but bind SARS-CoV2 virions as well. Alternatively, a combination of Losartan
or Baricitinib and Ang-(1-7) could prove to be the best treatment option.
Concluding remarks
The wide range of topics covered in my dissertation research have allowed me to
gather a large skill set that will be carried over to my forthcoming postdoctoral position
at the University of South Carolina School of Medicine in Dr. Mitzi Nagarkatti’s
laboratory. I will be working on a variety of topics such as: inflammation, PTSD, the
microbiome, and SARS-CoV2 spike phosphorylation which will allow me to use all of the
knowledge and skills that I have learned as a graduate student as I continue to grow as a
research scientist.
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APPENDIX A
THE CORONAVIRUS GENOME IS LIKE A SHIPPING LABEL THAT LETS
EPIDEMIOLOGISTS TRACK WHERE IT’S BEEN

Ely, B and Carter, T. Coversation.org. 2020. Creative Commons
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Following the coronavirus’s spread through the population – and anticipating its
next move – is an important part of the public health response to the new disease,
especially since containment is our only defense so far. Just looking at an infected
person doesn’t tell you where their version of the coronavirus came from, and SARSCoV-2 doesn’t have a bar code you can scan to allow you to track its travel history.
However, its genetic sequence is almost as good for providing some insight into where
the virus has been.
An organism’s genome is its complete genetic instructions. You can think of a
genome as a book, containing words made up of letters. Each “letter” in the genome is a
molecule called a nucleotide – in shorthand, an A, G, C, T or U. Mutations can occur
every time the virus replicates its genome, so that over time mutations accumulate in
the viral genome. For example, in place of the “word” CAT, the new virus has GAT. The
virus carries these minor modifications as it moves from one person to the next host.
These mutations behave like a passport stamp. No matter where you go next, previous
stamps in your passport still show where you’ve been.
Molecular geneticists like us can use this information to construct family trees
for the coronavirus. That allows us to trace the routes the virus has traveled through
space and time and start to answer questions like how quickly and easily does it spread
from one person to another?
Individual patient data help paint a big picture
Online databases have been collecting SARS-CoV-2 genomic nucleotide
sequences since mid December. Whenever a patient tests positive for SARS-CoV-2, a lab
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can determine the genome sequence of the infecting virus and upload it. As of late April,
more than 1,500 genome sequence samples have been deposited in GenBank, a publicly
available database run by the National Institutes of Health, and more than 13,000 are in
GISAID, the open-access Global Initiative on Sharing All Influenza Data.
Since each sequence is from a patient who is in a specific place in the world,
these viral genome sequences allow scientists to compare them and track where the
virus has been. The more similar the sequences from two particular viruses are, the
more closely related they are and the more recently they’ve shared a common ancestor.
The first SARS-CoV-2 genomic sequence uploaded to the GISAID’s website was collected
from a patient in early December 2019.
Of course, the viral mutations themselves do not tell researchers which country
they happened in. But since the databases record where particular patterns of
mutations have been observed, scientists can determine the route that each viral strain
has taken. The global map tracks the movement of the virus around the world. The data
recorded from thousands of patients show that SARS-Cov-2 originated in Wuhan China
and spread from there to the rest of the world.
The SARS-CoV-2 phylogenetic tree – the family tree that connects all the
sequenced coronavirus samples worldwide. The colors denote regional ‘branches’ of the
tree. nextstrain.org, CC BY
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Building maps out of sequences
The genetic data can play a big role in cracking public health mysteries, like how
the coronavirus has spread through the United States. For example, a traveler from
Wuhan arrived in Seattle on Jan. 15 and tested positive for the virus on Jan. 20.
On Feb. 28, scientists sequenced a virus sample from an American patient in
Seattle and found its mutation signature matched that of the virus from the Wuhan
traveler, plus three new mutations. GISAID has estimated the mutation rate at about
0.45 mutations per genome per week – so three mutations between the Jan. 20 case
and the Feb. 28 case fits that rate.
Based on the three new mutations, this version of the virus had been multiplying
undetected for about five weeks in the Seattle area. Since each infected person can
infect several other people without experiencing any symptoms themselves, the virus
could have spread to more than 100 people in five weeks.
Using the genome sequences to link the virus from the Jan. 15 traveler from
Wuhan with the Washington-based patient from the end of February alerted
Washington state officials that the virus was silently spreading through the population.
This undetected spreading of the virus in Seattle and elsewhere is one of the primary
reasons public health officials are calling for the public to stay home as much as
possible.
Another study detailed the path the virus took as it moved from Wuhan to
Shanghai to Germany to Italy to Mexico, stowing away in infected travelers. This study
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tracked infected individuals and compared their viral genomic sequences. Since
researchers could compare the viral mutations to those in known locations at specific
times, they were able to map out the phylogenetic tree – the family tree that shows
how the various virus genome sequences are related.
Using the GISAID estimated mutation rate and the phylogenetic tree, scientists
think the first time the coronavirus infected a person likely occurred in Wuhan in
November or early December 2019.
If the virus had been around much longer, the viruses of the first known patients
would have had a larger variety of mutations than they did.
Still tracking and learning from the sequences
The analysis of viral genomic sequences will continue to be a valuable tool for
tracking and containing the spread of SARS-CoV-2.
For instance, sequencing the genome of a virus from a newly infected patient could tell
you if it is a virus that has been circulating in the area for a while, or if it is a new
introduction from elsewhere.
Someone who’d been in northern Italy before travel restrictions were in place
brought the virus to Iceland. That initial outbreak was contained fairly quickly, but then
new forms of the virus were introduced from elsewhere in Europe.
A new study pending peer-review indicates that California also had multiple
introduction events with distinct viral lineages. For California, knowledge of the
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frequency of new introductions would be an important factor to consider as officials
devise ways to contain the virus.
Viral genome sequences can be informative in other ways as well. Eventually,
researchers may find that some forms of the virus are more virulent than others. In that
case, the sequence of the viral genome could help physicians decide which treatment
would be best for a particular patient.
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APPENDIX B
CHAPTER 2 SUPPLEMENTARY TABLES
Table B.1. qPCR primer list.
1. Heavy metal translocating P-type ATPase (895, 2931)
F: GCCTTTGAGCCTGTTTATCATC
R: AACTTGCCCTTGCGTAGT
2. Copper-translocating P-type ATPase (4024, 6375)
F: CTGTCCCAGATCGTTCAGATG
R: AGGATCGCCGAGAGGATAA
3. CpxP periplasmic heavy metal sensor (8476, 8916)
F: AAGCGTCCAGCATGTGAT
R: GACTGTTCGGTGAGGTTCTT
4. CusB efflux RND transporter subunit (13653, 15179)
F: TGACCTTGCTTGGCATGA
R: CACCGTGGATGTCGTCTG
5. CopB copper resistance protein (19784, 20860)
F: GATCGGTCCCTACTTCAATCTTC
R: CGCTCACCTCAAACCAGTAG
6. CzcD (69328, 69984)
F: CGCCACACCAGCCTATC
R: GACCAACACCACGACGAA
7. CzcA heavy metal efflux RND transporter (75025, 78267)
F: CGAAGGCACTGACCTCTATTT
R: ATCTGCGGCTGTACTGATG
8. TolC outer membrane efflux protein (85600, 86829)
F: TTCAGAGCGAGAACATCGG
R: GCCCAGCTCCAGCTTCT
9. CusA (88533, 91781)
F: GGTCAACGCCACCATTAAGA
R: GTTGCCTAGCAGAAGGAAGAG
10. Rho Control CB4 chromosome
F: GCCGACAAGCGGATCTT
R: CGCAGCACATAGGTCTTCT
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Table B.2. Predicted amino acid sequence identity of the
RepC (2a),ParB (2b), and MobA (2c) proteins coded by the
large plasmid group.
(A)
RepC
FWC2
FWC26p1
AP07
Ji-3-8
K31p1
K31p2
ParB
FWC2
FWC26p1
AP07
Ji-3-8
K31p1
K31p2
MobA
FWC2
FWC26p1
AP07
Ji-3-8
K31p1
K31p2

FWC2

FWC26p1

81.36%
74.29%
74.29%
70.36%
np

72.86%
72.86
68.03%
np

FWC2

AP07

Ji-3-8

94.05%
74.58% 74.10%
np
np
(B)
FWC26p1 AP07
Ji-3-8

59.78%
73.44%
71.34%
59.66%
58.17%

62.01
61.86%
61.38%
57.37%

FWC2

FWC26p1

99.30%
70.94%
76.35%
72.95%
46.38%

68.81
67.20%
69.62%
48.03%

82.22%
61.11%
59.84%

61.36%
56.60%
(C)
AP07
Ji-3-8

76.10%
82.73%
48.00%

77.31%
49.33%
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K31p1

np
K31p1

57.40%
K31p1

47.88%

Table B.3. Predicted amino acid sequence
identity of RepB(3a), ParB(3b), and MobA(3c)
for the medium plasmid group.
(A)
RepB
Cb4
Root1455 FWC26p2
CB4
Root1455 94.13%
FWC26p2 95.60% 96.48%
(B)
ParB
Cb4
Root1455 FWC26p2
CB4
Root1455 97.17%
FWC26p2 89.36% 85.80%
(C)
MobA
CB4
Root1455 FWC26p2
CB4
Root1455 96.47%
FWC26p2 89.94% 92.90%

Table B.4. Klett readings for addition of CuSO4 to CB4 and NA1000 duringmid-log
phase growth.
16um
NAcu1 NAcu2 NAC1 NAC2
CBC1
CBC2 CBcu1 CBcu2
T0
56
55
48
48
32
48
44
47
T1
73
70
71
73
42
61
54
63
T2
75
76
92
89
54
81
67
77
T3
83
81
116
114
76
100
88
99
T4
85
85
141
119
95
117
106
119
Slope
6.8
7.1
23.1 18.3
16
17.7 15.8
18
Average
6.95
20.7
16.85
16.9
%Growth 0.335749
1.002967
34%
100%
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APPENDIX C
CHAPTER 3 SUPPLEMENTARY TABLES
Table C.1. Primers for flanking regions of
copper-translocating P-type ATPase CB4 plasmid gene.
Primer

Nucleotide sequence

EcoF1

TTTTTTGAATTCCAATCGACGAGTCTATGGTCAC

ClaR1

TTTTTTATCGATAGGATCGCCGAGAGGATAA

BsmF2

TTTTTTGAATGCGGGTTGACGAAACCGATCTACTC

AvaR2

TTTTTTCCCGAGGGCCTGTTCCACCATGAA
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